Steven Gillis, Director at bluebird bio, Inc. (BLUE), sold 91,165 shares at $36.08 ($3.2M) on 2014-09-30, disclosed to the SEC on 2014-10-02.
Open-market sale of $3.2M BLUE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.08 | 32,095 | $1.2M | 36.0% |
| 2 | $34.75 | 11,516 | $400K | 12.4% |
| 3 | $34.87 | 47,554 | $1.7M | 51.6% |
| Total | $35.28 avg | 91,165 | $3.2M | 100% |
| Filing → |
| BOLD | BUY | 2024-04-04 | $3.2M | — | Filing → |
| VBIV | BUY | 2023-07-18 | $2.0M | — | Filing → |
| CDAK | BUY | 2020-10-20 | $3.5M | — | Filing → |